Compugen Ltd. Reports Q2 2025 Results
Ticker: CGEN · Form: 6-K · Filed: Aug 6, 2025 · CIK: 1119774
| Field | Detail |
|---|---|
| Company | Compugen Ltd (CGEN) |
| Form Type | 6-K |
| Filed Date | Aug 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 6-K, foreign-private-issuer
TL;DR
Compugen dropped Q2 2025 earnings on Aug 6th. Check the 6-K.
AI Summary
Compugen Ltd. reported its second quarter 2025 financial results on August 6, 2025. The filing is a Form 6-K, which is a report of a foreign private issuer. The company is based in Holon, Israel, and its fiscal year ends on December 31.
Why It Matters
This filing provides investors with an update on Compugen's financial performance for the second quarter of 2025, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial results filing and does not contain significant new risks.
Key Numbers
- Q2 2025 — Quarterly Results (Financial performance for the second quarter of 2025.)
Key Players & Entities
- Compugen Ltd. (company) — Registrant
- August 6, 2025 (date) — Date of press release
- 2025 (date) — Year of financial results
- Holon, Israel (location) — Company headquarters
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer.
When did Compugen Ltd. report its Q2 2025 results?
Compugen Ltd. reported its Q2 2025 results on August 6, 2025.
Where is Compugen Ltd. based?
Compugen Ltd. is based in Holon, Israel.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
What is the Commission File Number for Compugen Ltd.?
The Commission File Number for Compugen Ltd. is 000-30902.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on August 6, 2025 regarding COMPUGEN LTD (CGEN).